Comparative Pharmacology
Head-to-head clinical analysis: PENTIDS 250 versus POLYCILLIN N.
Peer-Reviewed Evidence
Head-to-head clinical analysis: PENTIDS 250 versus POLYCILLIN N.
PENTIDS '250' vs POLYCILLIN-N
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Penicillin G binds to penicillin-binding proteins (PBPs) located on the bacterial cell wall, inhibiting transpeptidase activity and cell wall synthesis, leading to bacterial lysis.
Ampicillin is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), disrupting peptidoglycan cross-linking, and activating autolytic enzymes. It is bactericidal against susceptible organisms.
250 mg orally every 8 hours.
1-2 g IV/IM every 4-6 hours
None Documented
None Documented
0.5-1 hour (prolonged in renal impairment; requires dose adjustment when CrCl <30 mL/min)
Terminal elimination half-life: 0.5-1 hour (normal renal function); increases to 7-10 hours in anuria. Prolonged in neonates (2-4 hours).
Primarily renal (60-90% as unchanged drug via glomerular filtration and tubular secretion); minor biliary/fecal (10-30%)
Renal: 60-80% unchanged via glomerular filtration and tubular secretion. Biliary: ~20% excreted in bile and feces. Small amount metabolized to penicilloic acid.
Category C
Category C
Penicillin Antibiotic
Penicillin Antibiotic